federal_register: E8-699
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E8-699 | Implantation or Injectable Dosage Form New Animal Drugs; Flunixin | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Norbrook Laboratories, Ltd. The supplemental ANADA provides for the veterinary prescription use of flunixin meglumine solution by intravenous injection in lactating dairy cattle for control of pyrexia associated with acute bovine mastitis. | 2008-01-16 | 2008 | 1 | https://www.federalregister.gov/documents/2008/01/16/E8-699/implantation-or-injectable-dosage-form-new-animal-drugs-flunixin | https://www.govinfo.gov/content/pkg/FR-2008-01-16/pdf/E8-699.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Norbrook Laboratories, Ltd. The supplemental ANADA provides for the veterinary... |